Conjunctivitis News and Research

RSS

Conjunctivitis is an eye infection that may cause redness and discharge from the eye, sometimes with pain or itching. It can be caused by bacteria or viruses.

New analysis reveals link between fast food consumption and increased risk of allergic diseases

A new Respirology review and analysis of published studies reveals a link between fast food consumption and an increased likelihood of having asthma, wheeze, and several other allergic diseases such as pollen fever, eczema, and rhino-conjunctivitis.

5 Jul 2018

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.

30 Jun 2018

Loyola Medicine study: Floppy eyelids linked to sleep apnea

A Loyola Medicine study is providing further evidence that floppy eyelids may be a sign of sleep apnea.

19 Jun 2018

Scientists develop artificial intelligence platform to diagnose many diseases

A platform that can diagnose several diseases with a high degree of precision using metabolic markers found in patients' blood has been developed by scientists at the University of Campinas in Brazil

13 Jun 2018

Tonsil and adenoid removal increases long-term risk of respiratory, allergic and infectious diseases

Tonsil and adenoid removal associated with long-term risks of respiratory, allergic and infectious diseases Removing tonsils and adenoids in childhood increases the long-term risk of respiratory, allergic and infectious diseases, according to researchers who have examined - for the first time - the long-term effects of the operations.

7 Jun 2018

New eye drop may be potentially effective in treating seasonal eye allergies

A recent study shows that a new eye drop may be a potentially effective treatment for seasonal eye allergies, a condition affecting millions of people worldwide.

4 May 2018

Acid-suppressing medicines and antibiotics in infancy linked to later allergic disease risk

The use of acid-suppressing medications or antibiotics in the first 6 months of infancy was associated with an increased risk for the subsequent development of allergic diseases in childhood.

2 Apr 2018

Improving Healthcare in the Community through Eye Examinations

Paul Morris is the Director of Professional Advancement for Specsavers Opticians in the UK and Ireland. The role involves furthering clinical scope, professional services, standards, training and forming future strategy for the group. He previously held the role of Director of Optometry Advancement.

From Specsavers 1 Dec 2017

Researchers discover mechanism behind skin inflammation in eczema

Publishing online this week in Cell Host & Microbe, researchers at Johns Hopkins report the discovery of a key underlying immune mechanism that explains why to how our skin becomes inflamed from conditions such as atopic dermatitis, more commonly known as eczema. Toxin-producing bacteria on the surface of our skin induces a protein that causes our own cells to react and cause inflammation.

8 Nov 2017

FDA grants approval for new test to detect Zika virus in blood donations

The U.S. Food and Drug Administration today approved the cobas Zika test, a qualitative nucleic acid test for the detection of Zika virus RNA in individual plasma specimens obtained from volunteer donors of whole blood and blood components, and from living organ donors.

6 Oct 2017

Study opens the lid on overprescribing of antibiotics for acute conjunctivitis

A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.

29 Jun 2017

Most people with acute conjunctivitis get wrong treatment, study suggests

A new study suggests that most people with acute conjunctivitis, or pink eye, are getting the wrong treatment. About 60 percent of patients are prescribed antibiotic eyedrops, even though antibiotics are rarely necessary to treat this common eye infection.

19 Jun 2017

Zika entry into India – cause for concern

The Zika virus has finally wormed its way into one of the largest and most densely populated countries in the world, India. The World Health Organization reported that surveillance efforts should be strengthened here in order to curb the menace and prevent its spread.

30 May 2017

Cancer Research UK-funded scientists to test effect of Zika virus on glioblastoma

In a revolutionary first, Cancer Research UK-funded scientists will test whether the Zika virus can destroy brain tumor cells, potentially leading to new treatments for one of the hardest to treat cancers.

19 May 2017

Brisbane researchers synthetically re-create Zika virus to better understand birth defects

Brisbane researchers have synthetically re-created Zika virus in the laboratory - a breakthrough which will help to understand the virus and the fetal brain defects it causes.

17 May 2017

University of Miami to begin clinical trial for testing DNA-based Zika vaccine

The University of Miami Miller School of Medicine will soon begin one of the nation's first full-scale Zika vaccine clinical trials testing the National Institutes of Health's (NIH) experimental DNA-based vaccine.

31 Mar 2017

Phase 2 clinical study of investigational Zika vaccine begins in the U.S., Central and South America

Vaccinations have begun in a multi-site Phase 2/2b clinical trial testing an experimental DNA vaccine designed to protect against disease caused by Zika infection.

31 Mar 2017

Researchers awarded CIHR grant to investigate how Zika virus changes host cells during infection

For more than a year, Tom Hobman and his research team have devoted most of their waking hours to a headlong pursuit of knowledge about the Zika virus.

16 Mar 2017

Innovative strategy uses genetically modified viruses to selectively attack tumor cells

Scientists at the IDIBAPS Biomedical Research Institute and at the Institute for Research in Biomedicine lead a study in which they have designed a new strategy to get genetically modified viruses to selectively attack tumor cells without affecting healthy tissues.